Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
3 News-Medical / Metabolic pressCoverage of the AOD-9604 Phase 2b obesity trial outcome (development discontinued ~2007)
They work through independent, complementary pathways
the label also warns that rash, hives, or swelling of the face, mouth, lips, or tongue can signal a hypersensitivity reaction requiring emergency care, though no generalized allergic reactions were documented in the original trials Because current supply comes only from compounded preparations rather than an FDA-verified finished product, potency, purity, and sterility can vary by pharmacy, and unregulated online sources carry added contamination or mislabeling risk
Palmetto Peptides supplies both BPC-157 and TB-500 as lyophilized research peptides with third-party HPLC purity and mass spectrometry identity verification
US$ 22.99
US$ 20.51
US$ 20.90
US$ 26.33
